CAS Shanghai Institute Pasteur develops influenza vaccine manufactured in Vero cells

Dec 31, 2014

The PR8 virus was adapted to Vero cells by continuous passaging, resulting in a Vero-adapted, high-yield PR8-4mut virus as a promising candidate for an influenza-vaccine donor virus

CAS news release, Dec. 31, 2014